Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.

Identifieur interne : 004016 ( PubMed/Checkpoint ); précédent : 004015; suivant : 004017

Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.

Auteurs : Marika J. Karkkainen [Finlande] ; Kari Alitalo [Finlande]

Source :

RBID : pubmed:11969367

Descripteurs français

English descriptors

Abstract

Vascular endothelial growth factor receptor-3 (VEGFR-3) mediates lymphatic endothelial cell (LEC) growth, migration, and survival by binding VEGF-C and VEGF-D. Recent studies have revealed new regulators of the lymphatic endothelium, such as the transcription factor Prox1, and the cell surface proteins podoplanin and lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1). Furthermore, the isolation of LECs now allows detailed molecular studies of the factors regulating the lymphatic vasculature. These studies are aimed at targeting the lymphatic vasculature in the treatment of various diseases, such as tumour metastasis and lymphoedema.

DOI: 10.1006/scdb.2001.0286
PubMed: 11969367


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:11969367

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.</title>
<author>
<name sortKey="Karkkainen, Marika J" sort="Karkkainen, Marika J" uniqKey="Karkkainen M" first="Marika J" last="Karkkainen">Marika J. Karkkainen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, Biomedicum Helsinki, Helsinki University Hospital and University of Helsinki, 00014 Helsinki, Finland. Marika.Karkkainen@Helsinki.Fl</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, Biomedicum Helsinki, Helsinki University Hospital and University of Helsinki, 00014 Helsinki</wicri:regionArea>
<wicri:noRegion>00014 Helsinki</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
<affiliation>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:11969367</idno>
<idno type="pmid">11969367</idno>
<idno type="doi">10.1006/scdb.2001.0286</idno>
<idno type="wicri:Area/PubMed/Corpus">004595</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004595</idno>
<idno type="wicri:Area/PubMed/Curation">004595</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004595</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004595</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004595</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.</title>
<author>
<name sortKey="Karkkainen, Marika J" sort="Karkkainen, Marika J" uniqKey="Karkkainen M" first="Marika J" last="Karkkainen">Marika J. Karkkainen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, Biomedicum Helsinki, Helsinki University Hospital and University of Helsinki, 00014 Helsinki, Finland. Marika.Karkkainen@Helsinki.Fl</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, Biomedicum Helsinki, Helsinki University Hospital and University of Helsinki, 00014 Helsinki</wicri:regionArea>
<wicri:noRegion>00014 Helsinki</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
<affiliation>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Seminars in cell & developmental biology</title>
<idno type="ISSN">1084-9521</idno>
<imprint>
<date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Angiogenesis Inducing Agents (metabolism)</term>
<term>Angiopoietin-2</term>
<term>Animals</term>
<term>Chylothorax (genetics)</term>
<term>DNA-Binding Proteins (genetics)</term>
<term>Endothelium, Vascular (physiology)</term>
<term>Forkhead Transcription Factors</term>
<term>Glycoproteins (metabolism)</term>
<term>Homeodomain Proteins (metabolism)</term>
<term>Humans</term>
<term>Integrins (metabolism)</term>
<term>Ligands</term>
<term>Lymphatic Metastasis (physiopathology)</term>
<term>Lymphatic System (embryology)</term>
<term>Lymphatic System (physiology)</term>
<term>Lymphedema (genetics)</term>
<term>Lymphedema (physiopathology)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Mice</term>
<term>Mice, Transgenic</term>
<term>Neovascularization, Physiologic</term>
<term>Neuropilin-2 (metabolism)</term>
<term>Oncogene Proteins (genetics)</term>
<term>Proto-Oncogene Proteins c-ets</term>
<term>Receptors, Chemokine (metabolism)</term>
<term>Transcription Factors (genetics)</term>
<term>Tumor Suppressor Proteins</term>
<term>Vascular Endothelial Growth Factor Receptor-3 (metabolism)</term>
<term>Vesicular Transport Proteins</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Agents angiogéniques (métabolisme)</term>
<term>Angiopoïétine-2</term>
<term>Animaux</term>
<term>Chylothorax (génétique)</term>
<term>Endothélium vasculaire (physiologie)</term>
<term>Facteurs de transcription (génétique)</term>
<term>Facteurs de transcription Forkhead</term>
<term>Glycoprotéines (métabolisme)</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Humains</term>
<term>Intégrines (métabolisme)</term>
<term>Ligands</term>
<term>Lymphoedème (génétique)</term>
<term>Lymphoedème (physiopathologie)</term>
<term>Métastase lymphatique (physiopathologie)</term>
<term>Neuropiline 2 (métabolisme)</term>
<term>Néovascularisation physiologique</term>
<term>Protéines de liaison à l'ADN (génétique)</term>
<term>Protéines du transport vésiculaire</term>
<term>Protéines oncogènes (génétique)</term>
<term>Protéines proto-oncogènes c-ets</term>
<term>Protéines suppresseurs de tumeurs</term>
<term>Protéines à homéodomaine (métabolisme)</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire (métabolisme)</term>
<term>Récepteurs aux chimiokines (métabolisme)</term>
<term>Souris</term>
<term>Souris transgéniques</term>
<term>Système lymphatique (embryologie)</term>
<term>Système lymphatique (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DNA-Binding Proteins</term>
<term>Oncogene Proteins</term>
<term>Transcription Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Angiogenesis Inducing Agents</term>
<term>Glycoproteins</term>
<term>Homeodomain Proteins</term>
<term>Integrins</term>
<term>Membrane Glycoproteins</term>
<term>Neuropilin-2</term>
<term>Receptors, Chemokine</term>
<term>Vascular Endothelial Growth Factor Receptor-3</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Angiopoietin-2</term>
<term>Forkhead Transcription Factors</term>
<term>Ligands</term>
<term>Proto-Oncogene Proteins c-ets</term>
<term>Tumor Suppressor Proteins</term>
<term>Vesicular Transport Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="embryologie" xml:lang="fr">
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="embryology" xml:lang="en">
<term>Lymphatic System</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Chylothorax</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Chylothorax</term>
<term>Facteurs de transcription</term>
<term>Lymphoedème</term>
<term>Protéines de liaison à l'ADN</term>
<term>Protéines oncogènes</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Agents angiogéniques</term>
<term>Glycoprotéines</term>
<term>Glycoprotéines membranaires</term>
<term>Intégrines</term>
<term>Neuropiline 2</term>
<term>Protéines à homéodomaine</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire</term>
<term>Récepteurs aux chimiokines</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Endothélium vasculaire</term>
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Endothelium, Vascular</term>
<term>Lymphatic System</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Lymphoedème</term>
<term>Métastase lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Lymphatic Metastasis</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Transgenic</term>
<term>Neovascularization, Physiologic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Angiopoïétine-2</term>
<term>Animaux</term>
<term>Facteurs de transcription Forkhead</term>
<term>Humains</term>
<term>Ligands</term>
<term>Néovascularisation physiologique</term>
<term>Protéines du transport vésiculaire</term>
<term>Protéines proto-oncogènes c-ets</term>
<term>Protéines suppresseurs de tumeurs</term>
<term>Souris</term>
<term>Souris transgéniques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Vascular endothelial growth factor receptor-3 (VEGFR-3) mediates lymphatic endothelial cell (LEC) growth, migration, and survival by binding VEGF-C and VEGF-D. Recent studies have revealed new regulators of the lymphatic endothelium, such as the transcription factor Prox1, and the cell surface proteins podoplanin and lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1). Furthermore, the isolation of LECs now allows detailed molecular studies of the factors regulating the lymphatic vasculature. These studies are aimed at targeting the lymphatic vasculature in the treatment of various diseases, such as tumour metastasis and lymphoedema.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">11969367</PMID>
<DateCreated>
<Year>2002</Year>
<Month>04</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2002</Year>
<Month>11</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2012</Year>
<Month>03</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1084-9521</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2002</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Seminars in cell & developmental biology</Title>
<ISOAbbreviation>Semin. Cell Dev. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.</ArticleTitle>
<Pagination>
<MedlinePgn>9-18</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Vascular endothelial growth factor receptor-3 (VEGFR-3) mediates lymphatic endothelial cell (LEC) growth, migration, and survival by binding VEGF-C and VEGF-D. Recent studies have revealed new regulators of the lymphatic endothelium, such as the transcription factor Prox1, and the cell surface proteins podoplanin and lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1). Furthermore, the isolation of LECs now allows detailed molecular studies of the factors regulating the lymphatic vasculature. These studies are aimed at targeting the lymphatic vasculature in the treatment of various diseases, such as tumour metastasis and lymphoedema.</AbstractText>
<CopyrightInformation>Copyright 2002 Elsevier Science Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Karkkainen</LastName>
<ForeName>Marika J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, Biomedicum Helsinki, Helsinki University Hospital and University of Helsinki, 00014 Helsinki, Finland. Marika.Karkkainen@Helsinki.Fl</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alitalo</LastName>
<ForeName>Kari</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HD37243</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Semin Cell Dev Biol</MedlineTA>
<NlmUniqueID>9607332</NlmUniqueID>
<ISSNLinking>1084-9521</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D043925">Angiogenesis Inducing Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D042702">Angiopoietin-2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C086924">Elk3 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C490441">Gp38 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016023">Integrins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C119248">LYVE1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D039943">Neuropilin-2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015513">Oncogene Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C117468">PDPN protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050783">Proto-Oncogene Proteins c-ets</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019707">Receptors, Chemokine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025521">Tumor Suppressor Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C492273">Xlkd1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C113256">integrin alpha 9 beta 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C082078">mesenchyme fork head 1 protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C102225">prospero-related homeobox 1 protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="D040321">Vascular Endothelial Growth Factor Receptor-3</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D043925" MajorTopicYN="N">Angiogenesis Inducing Agents</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D042702" MajorTopicYN="N">Angiopoietin-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002916" MajorTopicYN="N">Chylothorax</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018398" MajorTopicYN="N">Homeodomain Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016023" MajorTopicYN="N">Integrins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008208" MajorTopicYN="N">Lymphatic System</DescriptorName>
<QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018919" MajorTopicYN="N">Neovascularization, Physiologic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D039943" MajorTopicYN="N">Neuropilin-2</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015513" MajorTopicYN="N">Oncogene Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050783" MajorTopicYN="N">Proto-Oncogene Proteins c-ets</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019707" MajorTopicYN="N">Receptors, Chemokine</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D025521" MajorTopicYN="N">Tumor Suppressor Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D040321" MajorTopicYN="N">Vascular Endothelial Growth Factor Receptor-3</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>100</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2002</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2002</Year>
<Month>11</Month>
<Day>28</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2002</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">11969367</ArticleId>
<ArticleId IdType="doi">10.1006/scdb.2001.0286</ArticleId>
<ArticleId IdType="pii">S1084-9521(01)90286-1</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Finlande</li>
</country>
<region>
<li>Uusimaa</li>
</region>
<settlement>
<li>Helsinki</li>
</settlement>
<orgName>
<li>Université d'Helsinki</li>
</orgName>
</list>
<tree>
<country name="Finlande">
<noRegion>
<name sortKey="Karkkainen, Marika J" sort="Karkkainen, Marika J" uniqKey="Karkkainen M" first="Marika J" last="Karkkainen">Marika J. Karkkainen</name>
</noRegion>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004016 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004016 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:11969367
   |texte=   Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:11969367" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024